오르니프레신

Ornipressin
오르니프레신
Ornipressin.png
이름
IUPAC 이름
(2S)-N-[(2S)-5-Amino-1-[(2-amino-2-oxoethyl)amino]- 1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)- 19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl] -6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17- pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
식별자
3D 모델(JSmol)
켐스파이더
ECHA InfoCard 100.020.231 Edit this at Wikidata
메슈 오르니프레신
펍켐 CID
유니
  • InChI=1S/C45H63N13O12S2/c46-16-4-8-28(39(64)51-21-37(50)62)53-44(69)34-9-5-17-58(34)45(70)33-23-72-71-22-27(47)38(63)54-30(19-25-10-12-26(59)13-11-25)42(67)55-31(18-24-6-2-1-3-7-24)41(66)52-29(14-15-35(48)60)40(65)56-32(20-36(49)61)43(68)57-33/h1-3,6-7,10-13,27-34,59H,4-5,8-9,14-23,46-47H2,(H2,48,60)(H2,49,61)(H2,50,62)(H,51,64)(H,52,66)(H,53,69)(H,54,63)(H,55,67)(H,56,65)(H,5,65)/t27-,28-,29-,30-,31-,32-,33-/34-/m0/s1 수표Y
    키: MUNMIGOEDGHVLE-LGYYRGSSA-N 수표Y
  • InChI=1/C45H63N13O12S2/c46-16-4-8-28(39(64)51-21-37(50)62)53-44(69)34-9-5-17-58(34)45(70)33-23-72-71-22-27(47)38(63)54-30(19-25-10-12-26(59)13-11-25)42(67)55-31(18-24-6-2-1-3-7-24)41(66)52-29(14-15-35(48)60)40(65)56-32(20-36(49)61)43(68)57-33/h1-3,6-7,10-13,27-34,59H,4-5,8-9,14-23,46-47H2,(H2,48,60)(H2,49,61)(H2,50,62)(H,51,64)(H,52,66)(H,53,69)(H,54,63)(H,55,67)(H,56,65)(H,56,65)/t27-,28-,29-,30-,31-,33-,34-/m0/s1
    키: MUNMIGOEDGHVLE-LGYYRKSBZ
  • NC(=O)CNC(=O)[C@H](CCCN)NC(=O)[C@H]1CCN1C(=O)[C@H]4NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)]NC(=O)[C@H](Cc2ccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC4)CC(N)=O
특성.
C45H63N13O12S2
어금질량 1042.19 g/1920
약리학
H01BA05(WHO)
달리 명시된 경우를 제외하고, 표준 상태(25°C [77°F], 100 kPa)의 재료에 대한 데이터가 제공된다.
check 이버라이시수표Y☒N(?)
Infobox 참조 자료

오르니프레신은 혈관수축제,[1][2] 지혈제, 신약이다.

참조

  1. ^ H. Fruhstofer, M.D., M. Heisler, M.D. (1994). "Dose-response relation of ornipressin with regard to vasoconstriction in human skin". Br. J. Anaesth. 73 (2): 220–224. doi:10.1093/bja/73.2.220.{{cite journal}}: CS1 maint : 복수이름 : 작성자 목록(링크)
  2. ^ Marc De Kock, MD, Pierre-Francois Laterre, MD, Patricia Andruetto, MD, Lionel Vanderessen, MD, Sylvie Dekrom, MD, Bernard Vanderick, MD and Patricia Lavand’homme, MD (June 2000). "Ornipressin (Por 8): An Efficient Alternative to Counteract Hypotension During Combined General/Epidural Anesthesia". Anesthesia & Analgesia. 90 (6): 1301–1307. doi:10.1097/00000539-200006000-00008.{{cite journal}}: CS1 maint : 복수이름 : 작성자 목록(링크)



Stub icon

이 호르몬 준비물은 단조롭다.위키피디아를 확장하여 도울 수 있다.